Transformative Biotech, LLC (T-Bio) has announced that Nicholas Meyerson, PhD, has joined the company as Vice President of Product Strategy and Partnerships. Dr. Meyerson will lead product planning, customer requirements, partner evaluations, and non-dilutive funding strategy. He was co-founder and CEO of Darwin Biosciences, a Boulder company spun out of the University of Colorado Boulder, and brings point-of-care diagnostics, partnership, and funding experience to T-Bio’s patented DirectAmp™ direct-to-PCR technologies.
Transformative Biotech Welcomes Nicholas Meyerson, PhD
